EIF4A1 has been reported to directly determine the selective translation of oncoproteins, such as myc, myb, notch, cdk6, bcl-2 and ROCK1, which are critical regulators contributing to cancer survival, proliferation, migration, invasion, metastasis and chemoresistance [14,33,34]. Here, BCL2 is linked to cancer.